TC BioPharm (Holdings) PLC (TCBP)
1.50
+0.07
(+4.90%)
USD |
NASDAQ |
May 01, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
TC BioPharm Cash and Short Term Investments (Quarterly): 3.137M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.137M |
| June 30, 2023 | 2.420M |
| December 31, 2022 | 5.819M |
| June 30, 2022 | 7.274M |
| Date | Value |
|---|---|
| December 31, 2021 | 2.114M |
| September 30, 2021 | 2.082M |
| December 31, 2020 | 1.019M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.019M
Minimum
Dec 2020
7.274M
Maximum
Jun 2022
3.409M
Average
2.420M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 146.94M |
| Biodexa Pharmaceuticals Plc | 7.606M |
| NuCana PLC | 21.94M |
| Autolus Therapeutics PLC | 239.57M |
| Mereo BioPharma Group PLC | 57.42M |